- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Genome profiling of ERBB2-amplified breast cancers ; volume:10 ; number:1 ; day:8 ; month:10 ; year:2010 ; pages:1-18 ; date:12.2010
BMC cancer ; 10, Heft 1 (8.10.2010), 1-18, 12.2010
- Urheber
-
Sircoulomb, Fabrice
- Beteiligte Personen und Organisationen
-
Bekhouche, Ismahane
Finetti, Pascal
Adélaïde, José
Hamida, Azza Ben
Bonansea, Julien
Raynaud, Stéphane
Innocenti, Charlène
Charafe-Jauffret, Emmanuelle
Tarpin, Carole
Ayed, Farhat Ben
Viens, Patrice
Jacquemier, Jocelyne
Bertucci, François
Birnbaum, Daniel
Chaffanet, Max
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-10-539
- URN
-
urn:nbn:de:1111-2016030357105
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sircoulomb, Fabrice
- Bekhouche, Ismahane
- Finetti, Pascal
- Adélaïde, José
- Hamida, Azza Ben
- Bonansea, Julien
- Raynaud, Stéphane
- Innocenti, Charlène
- Charafe-Jauffret, Emmanuelle
- Tarpin, Carole
- Ayed, Farhat Ben
- Viens, Patrice
- Jacquemier, Jocelyne
- Bertucci, François
- Birnbaum, Daniel
- Chaffanet, Max
- SpringerLink (Online service)
Ähnliche Objekte (12)
Mitochondrial DNA copy number instability in ERBB2-amplified breast cancer tumors
A reason why the ERBB2 gene is amplified and not mutated in breast cancer
Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancers
Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets
Genome-wide enhancer RNA profiling adds molecular links between genetic variation and human cancers
Accurate variant detection across non-amplified and whole genome amplified DNA using targeted next generation sequencing
Transcriptome and genome evolution during HER2-amplified breast neoplasia
ERBB2/HOXB13 co-amplification with interstitial loss of BRCA1 defines a unique subset of breast cancers
Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial
Variant discovery in targeted resequencing using whole genome amplified DNA
The FAM3C locus that encodes interleukin-like EMT inducer (ILEI) is frequently co-amplified in MET-amplified cancers and contributes to invasiveness
Amplified imagination
Mitochondrial DNA copy number instability in ERBB2-amplified breast cancer tumors
A reason why the ERBB2 gene is amplified and not mutated in breast cancer
Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancers
Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets
Genome-wide enhancer RNA profiling adds molecular links between genetic variation and human cancers
Accurate variant detection across non-amplified and whole genome amplified DNA using targeted next generation sequencing
Transcriptome and genome evolution during HER2-amplified breast neoplasia
ERBB2/HOXB13 co-amplification with interstitial loss of BRCA1 defines a unique subset of breast cancers
Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial
Variant discovery in targeted resequencing using whole genome amplified DNA
The FAM3C locus that encodes interleukin-like EMT inducer (ILEI) is frequently co-amplified in MET-amplified cancers and contributes to invasiveness
Amplified imagination
Mitochondrial DNA copy number instability in ERBB2-amplified breast cancer tumors
A reason why the ERBB2 gene is amplified and not mutated in breast cancer
Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancers
Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets
Genome-wide enhancer RNA profiling adds molecular links between genetic variation and human cancers
Accurate variant detection across non-amplified and whole genome amplified DNA using targeted next generation sequencing
Transcriptome and genome evolution during HER2-amplified breast neoplasia
ERBB2/HOXB13 co-amplification with interstitial loss of BRCA1 defines a unique subset of breast cancers
Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial
Variant discovery in targeted resequencing using whole genome amplified DNA
The FAM3C locus that encodes interleukin-like EMT inducer (ILEI) is frequently co-amplified in MET-amplified cancers and contributes to invasiveness